IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Jubilant consolidates pharma business under Singapore subsidiary

7:38 AM MDT | October 6, 2013 | Natasha Alperowicz

Jubilant Life Sciences (Noida, India), a pharmaceuticals and life sciences company, said on Friday that its board of directors voted to transfer the active pharmaceutical ingredients (APIs), dosage forms business, and the 18% shareholding held by Jubilant in Jubilant Pharma Holding, and the 77.65% shares in Belgium-based Jubilant Pharma NV to a new company to be incorporated in India as a wholly owned subsidiary of Jubilant Pharma Ltd. Singapore, which is a wholly owned subsidiary of Jubilant. The transfer is being made for a total of 11.45 billion Indian rupees...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa